98 related articles for article (PubMed ID: 31467180)
1. Inhibition of AKT Sensitizes Cancer Cells to Antineoplastic Drugs by Downregulating Flap Endonuclease 1.
Zhu H; Wu C; Wu T; Xia W; Ci S; He W; Zhang Y; Li L; Zhou S; Zhang J; Edick AM; Zhang A; Pan FY; Hu Z; He L; Guo Z
Mol Cancer Ther; 2019 Dec; 18(12):2407-2420. PubMed ID: 31467180
[TBL] [Abstract][Full Text] [Related]
2. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
[TBL] [Abstract][Full Text] [Related]
3. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.
Lu X; Liu R; Wang M; Kumar AK; Pan F; He L; Hu Z; Guo Z
Oncogene; 2020 Jan; 39(1):234-247. PubMed ID: 31471584
[TBL] [Abstract][Full Text] [Related]
5. YY1 suppresses FEN1 over-expression and drug resistance in breast cancer.
Wang J; Zhou L; Li Z; Zhang T; Liu W; Liu Z; Yuan YC; Su F; Xu L; Wang Y; Zhou X; Xu H; Hua Y; Wang YJ; Zheng L; Teng YE; Shen B
BMC Cancer; 2015 Feb; 15():50. PubMed ID: 25885449
[TBL] [Abstract][Full Text] [Related]
6. FEN1 mediates miR-200a methylation and promotes breast cancer cell growth
Zeng X; Qu X; Zhao C; Xu L; Hou K; Liu Y; Zhang N; Feng J; Shi S; Zhang L; Xiao J; Guo Z; Teng Y; Che X
FASEB J; 2019 Oct; 33(10):10717-10730. PubMed ID: 31266372
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression.
Chen B; Zhang Y; Wang Y; Rao J; Jiang X; Xu Z
J Steroid Biochem Mol Biol; 2014 Sep; 143():11-8. PubMed ID: 24486718
[TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes.
Ward TA; McHugh PJ; Durant ST
PLoS One; 2017; 12(6):e0179278. PubMed ID: 28628639
[TBL] [Abstract][Full Text] [Related]
9. The FEN1 L209P mutation interferes with long-patch base excision repair and induces cellular transformation.
Sun H; He L; Wu H; Pan F; Wu X; Zhao J; Hu Z; Sekhar C; Li H; Zheng L; Chen H; Shen BH; Guo Z
Oncogene; 2017 Jan; 36(2):194-207. PubMed ID: 27270424
[TBL] [Abstract][Full Text] [Related]
10. PRMT1 is critical to FEN1 expression and drug resistance in lung cancer cells.
He L; Hu Z; Sun Y; Zhang M; Zhu H; Jiang L; Zhang Q; Mu D; Zhang J; Gu L; Yang Y; Pan FY; Jia S; Guo Z
DNA Repair (Amst); 2020 Nov; 95():102953. PubMed ID: 32861926
[TBL] [Abstract][Full Text] [Related]
11. Letrozole improves the sensitivity of breast cancer cells overexpressing aromatase to cisplatin via down-regulation of FEN1.
Wang Y; Li S; Zhu L; Zou J; Jiang X; Chen M; Chen B
Clin Transl Oncol; 2019 Aug; 21(8):1026-1033. PubMed ID: 30712236
[TBL] [Abstract][Full Text] [Related]
12. Jianpi-yangwei decoction inhibits DNA damage repair in the drug resistance of gastric cancer by reducing FEN1 expression.
Huang W; Tang H; Wen F; Lu X; Li Q; Shu P
BMC Complement Med Ther; 2020 Jun; 20(1):196. PubMed ID: 32586310
[TBL] [Abstract][Full Text] [Related]
13. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
14. FEN1 is overexpressed in testis, lung and brain tumors.
Nikolova T; Christmann M; Kaina B
Anticancer Res; 2009 Jul; 29(7):2453-9. PubMed ID: 19596913
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of FEN1 promotes DNA damage and enhances chemotherapeutic response in prostate cancer cells.
Wang Z; Yong C; Fu Y; Sun Y; Guo Z; Liu SB; Hu Z
Med Oncol; 2023 Jul; 40(8):242. PubMed ID: 37452976
[TBL] [Abstract][Full Text] [Related]
16. Identification of human flap endonuclease 1 (FEN1) inhibitors using a machine learning based consensus virtual screening.
Deshmukh AL; Chandra S; Singh DK; Siddiqi MI; Banerjee D
Mol Biosyst; 2017 Jul; 13(8):1630-1639. PubMed ID: 28685785
[TBL] [Abstract][Full Text] [Related]
17. Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis.
Wang K; Xie C; Chen D
Int J Mol Med; 2014 May; 33(5):1268-74. PubMed ID: 24590400
[TBL] [Abstract][Full Text] [Related]
18. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.
Lu JJ; Fu L; Tang Z; Zhang C; Qin L; Wang J; Yu Z; Shi D; Xiao X; Xie F; Huang W; Deng W
Oncotarget; 2016 Jan; 7(3):2985-3001. PubMed ID: 26672764
[TBL] [Abstract][Full Text] [Related]
19. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]